Elite Pharmaceuticals Inc (ELTP) financial statements (2020 and earlier)

Company profile

Business Address 165 LUDLOW AVENUE
NORTHVALE, NJ 07647
State of Incorp. NV
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2232456
Cash and cash equivalents2232456
Receivables3211111
Inventory, net of allowances, customer advances and progress billings4455444
Inventory4455444
Other undisclosed current assets1001101
Total current assets:989991011
Noncurrent Assets
Operating lease, right-of-use asset001 
Property, plant and equipment8888999
Intangible assets, net (including goodwill)7777888
Intangible assets, net (excluding goodwill)7777888
Other noncurrent assets0000000
Total noncurrent assets:15151616171717
TOTAL ASSETS:24242424262728
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5665543
Accounts payable1221211
Accrued liabilities4444332
Deferred revenue011 
Debt1111111
Due to related parties1      
Other undisclosed current liabilities0001111
Total current liabilities:8787755
Noncurrent Liabilities
Long-term debt and lease obligation2222222
Long-term debt, excluding current maturities2222222
Operating lease, liability000 
Liabilities, other than long-term debt0111111
Deferred revenue000 
Due to related parties 111111
Other liabilities0000000
Other undisclosed noncurrent liabilities5213233
Total noncurrent liabilities:7656667
Total liabilities:15131213131212
Temporary equity, carrying amount 141414141414
Stockholders' equity
Stockholders' equity attributable to parent9(3)(2)(3)(0)23
Preferred stock14      
Common stock1111111
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital150150149149148148147
Accumulated deficit(155)(153)(152)(152)(149)(147)(144)
Total stockholders' equity:9(3)(2)(3)(0)23
TOTAL LIABILITIES AND EQUITY:24242424262728

Income statement (P&L) ($ in millions)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
Revenues5531312
Cost of revenue(2)(3)(2)(1)(2)(1)(2)
Gross profit:3111111
Operating expenses(2)(2)(2)(3)(4)(3)(2)
Operating income (loss):1(0)(1)(2)(3)(3)(2)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(3)(1)1(1) 00
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(2)(2)0(3)(3)(3)(2)
Other undisclosed income (loss) from continuing operations before income taxes000(0)0 0
Income (loss) from continuing operations before income taxes:(2)(2)0(3)(2)(3)(2)
Other undisclosed income from continuing operations   1   
Income (loss) from continuing operations:(2)(2)0(3)(2)(3)(2)
Other undisclosed loss before gain (loss) on sale of properties   (1)   
Income (loss) before gain (loss) on sale of properties:(2)(2)0(3)(2)(3)(2)
Other undisclosed net loss (0)     
Net income (loss):(2)(2)0(3)(2)(3)(2)
Other undisclosed net income attributable to parent   1   
Net income (loss) attributable to parent:(2)(2)0(3)(2)(3)(2)
Other undisclosed net income available to common stockholders, basic     0 
Net income (loss) available to common stockholders, basic:(2)(2)0(3)(2)(3)(2)
Other undisclosed net income (loss) available to common stockholders, diluted  (2)1(0)  
Net loss available to common stockholders, diluted:(2)(2)(1)(2)(3)(3)(2)

Comprehensive Income ($ in millions)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
Net income (loss):(2)(2)0(3)(2)(3)(2)
Comprehensive income (loss), net of tax, attributable to parent:(2)(2)0(3)(2)(3)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: